News & Updates

In an expanded analysis presented at SCAI 2022, recipients of the Harmony transcatheter pulmonary valve (TPV) continued to demonstrate favourable clinical and haemodynamic outcomes, confirming previous results and showing continued device success across studies and valve types at 1 year and beyond.

Institutions differ considerably in their parental benefits and policies among cardiovascular training programs internationally, which underscores disparities in real-world experiences, reveals a study.

Takotsubo syndrome (TTS) in male patients exhibit a distinct high-risk phenotype that needs close in-hospital monitoring and long-term follow-up, according to a study.

The risk of cardiovascular events, such as heart failure (HF) and myocardial infarction (MI), are comparable across different sodium-glucose cotransporter 2 (SGLT2) inhibitors, according to a recent real-world Japan study.

New drug applications approved by US FDA as of 16-31 May 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.